Marketresearchnews

Wednesday, 26 August 2020

Particle Counter Market To Observe Strong Development By 2019

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Particle Counter Market Research Report – Forecast To 2025” Gives Industry Size, Top Players And Worldwide Demand

The obsession with cleanroom technology across industrial sectors has led to the development of products able to track contaminants. Presence of contaminants can dilute solutions or send out wrong readings in sensitive environments. Particle counters are instruments which can detect and count physical particles. It can calculate the volume of particles in the air in cleanrooms and workplaces. Market Research Future (MRFR) has outlined the various factors and restraints enveloping the global particle counter market in its latest report as well as predictions for the period of 2019 to 2025 (forecast period). The pervasion of the COVID-19 and its effects are analyzed in detail in the report.

ALSO READ : https://www.medgadget.com/2020/06/covid-19-pandemic-to-leverage-growth-of-particle-counter-market-2020-industry-analysis-growth-size-regional-outlook-top-companies-competitive-landscape-future-trends-by-2025.html

Particle Counter Market Scope

Global particle counter market size is expected to cross USD 168.2 Million by 2025 at a CAGR of 7.1% during the forecast period of 2019 to 2025.

Production of drugs, vaccines, and other chemicals by chemicals, pharmaceuticals, and other industries can drive the need for particle counters. Strict regulations pertaining to the removal of contaminants and removal of harmful bacteria can push the market demand greatly. Investments in research and development activities can fuel market demand as well. According to the National Institute for Health Research, the Association of the British Pharmaceutical Industry (ABPI) had invested close to USD 4.46 billion in 2015.

But high costs of particle counters can limit market growth.

Particle Counter Market Competition

key players of the global particle counter market are –

Climet Instruments Company
Lighthouse Worldwide Solutions Inc.
Setra Systems
TSI Incorporated
Met One Instruments Inc.
Chemtrac Inc.
Particle Measuring Systems Inc.
Rion Co. Ltd.
Beckman Coulter

Particle Counter Market Segmentation

The global particle counter market is segmented by product type, modularity, technology, and end user.

By product type, it is divided into liquid and airborne particle counters. Airborne particle counters are expected to take the lead in the market till 2025. This can be attributed to its sensitivity towards dust particles and ability to monitor room contamination. On the other hand, liquid particle counters can capture a significant market share owing to application in automotive, heavy machinery, and aviation & space exploration.

By modularity, it is segmented into handheld, portable, and remote particle counters.

By technology, it is divided into offline and online particle counters. Online particle counters can hold maximum market share owing to its ability to detect particles in lubricating and hydraulic systems.

By end user, it is segmented into pharmaceutical industry, medical device industry, research laboratories, and others.

Particle Counter Market Regional Analysis

Europe, the Americas, Asia Pacific (APAC), and the Middle East & Africa (MEA) are prime regions considered in the global particle counter market.

The Americas held the largest market share in 2018. It is likely to dominate the market during the forecast period owing to adoption of particle counters and regulations enforced by federal agencies. Launch of new products by players and expansion of product portfolios can encourage market growth.

Europe is expected to induce heavy demand for the global market due to the need for particle counters in medical device and pharmaceutical industries. The large population, a spike in healthcare spending, and support from governments are primary drivers of the regional market.

APAC accounted for the third position in the market due to investments by American and European stalwarts, developments in healthcare manufacturers, large number of research organizations, low manufacturing costs, and economical labor costs.

The MEA region accounted for the lowest market share due to limited investments in modernization of healthcare infrastructure.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/particle-counter-market-8776

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Clear Aligners Market Volume Forecast And Value Chain Analysis 2019

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Clear Aligners Market Research Report – Forecast To 2025” Gives Industry Size, Top Players And Worldwide Demand

Clear Aligners Market Analysis

The global clear aligners market is likely to touch USD 7019.96 million at a 20.80% CAGR between 2019- 2025, according to the recent Market Research Future (MRFR) report. Clear aligners, simply put, are a substitute to traditional braces that are designed for arranging teeth into proper position. Akin to braces, it uses a gradual force for controlling the movement of tooth sans brackets or metal wires. Clear aligners are manufactured with durable plastic that is fabricated to fit every individual’s mouth.

ALSO READ : https://www.medgadget.com/2020/06/clear-aligners-market-to-touch-usd-7019-96-million-at-20-80-cagr-by-2025-mrfr-provides-industry-growth-size-covid-19-analysis-regional-data.html

Various factors are adding to the global clear aligners market growth. Such factors, according to the new MRFR report, include growing popularity of aesthetic dentistry especially among the young population, high healthcare expenditure in developing and developed regions, increase in geriatric population, rising prevalence of dental diseases, and rapid technological advances that is helping the evolution of dentistry through advanced dental devices.

On the contrary, high treatment time, lack of awareness, and availability of cost-effective products are factors that may limit the clear aligners market growth over the forecast period.

Clear Aligners Market Key Players

Leading players profiled in the clear aligners market report include

Danaher Corporation
3M
Institut Straumann AG
Align Technology Inc.
Clarus Company
Dentsply Sirona

Covid-19 Analysis /Covid-19 Impact on Clear Aligners Market

Clear aligners is a major market that has been impacted negatively by the COVID-19 pandemic. Its production has been disrupted the world over. This pandemic has forced several dentists in slashing their staff and their services causing a delay in several appointments resulting in increased complications. Besides, numerous events related to clear and dental aligners have also been suspended. Such events were to be conducted to boost awareness about clear aligners and also improve revenue. Towards the ending of the second quarter, in India, Japan, South Korea, and China, pandemic situation and quarantine is augmenting and showing obvious recovery signs. It is predicted that numerous practitioners will begin their service via implementing local and international guidance towards the end of the second quarter. European and North American countries are likely to resume dental services steadily by following guidelines, and towards the end of third-quarter, the maximum amount of clear aligner production is likely to resume normally.

Given the debilitating of COVID-19 (Coronavirus) Impact on Clear Aligners Market, companies are on the lookout for starting production lines. Get an inside look at the market prospects and its future decisions in light of the pandemic and other such unforeseen circumstances.

Clear Aligners Market Segmentation

The MRFR report offers an inclusive segmental analysis of the global clear aligners market report based on distribution channel, product type, and age.

By types, the clear aligners market is segmented into medium, hard, and soft. Of these, the hard segment will lead the market over the forecast period.

By age groups, the clear aligners market is segmented into adult and teenager. Of these, the adult segment will dominate the market over the forecast period while the teenager segment will grow at the highest CAGR.

By distribution channel, the clear aligners market is segmented into direct sales, laboratories, and others. Of these, direct sales will have a major share in the market over the forecast period.

Clear Aligners Market Regional Analysis

Based on the region, the global clear aligners market report covers the recent trends & growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will dominate the market over the forecast period for aesthetic dentistry, vast specialized services, growing demand for advanced technologies, rising healthcare expenditure, and the presence of several key players in the region.

The global clear aligners market in Europe is predicted to hold the second-largest share over the forecast period for increasing demand for dental procedures, rising prevalence of oral problems, the growing significance of treatment, diagnosis, and planning in implant dentistry, and increasing application of techniques that are technologically advanced.

The global clear aligners market in the APAC region is predicted to grow at a quick rate over the forecast period for lots of opportunities, constantly growing economies, increasing disposable income, improving economies, and developments in healthcare.

The global clear aligners market in the MEA is predicted to have steady growth over the forecast period for the demand for improved teeth-related treatments and an increasing number of dental abnormality cases.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/clear-aligners-market-6974

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Whole Exome Sequencing Market 2019 Analysis, Opportunities And Forecast To 2025

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Whole Exome Sequencing Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

As per Market Research Future (MRFR) analysis, the global whole exome sequencing market is estimated to reach USD 2,696.03 million with a CAGR of 19.80% from 2019 to 2025 (forecast period).

Whole exome sequencing is a broadly used next-generation sequencing (NGS) method to determine the nucleotide sequence primarily of protein-coding regions of individual-related sequences, reflecting approximately 1% of the complete DNA sequence. Human exome accounts for less than 2% of the genome but contains -85% of known disease-related variants. This is the primary explanation for the use of exome in the detection and determination of genetic variants that cause different diseases, such as Miller syndrome and Alzheimer's.

ALSO READ : https://www.marketwatch.com/press-release/covid-19-outbreak-impact-on-whole-exome-sequencing-market-2020-industry-analysis-global-size-share-top-company-profile-regional-outlook-2020-06-02?tesla=y

Whole Exome Sequencing Market Dynamics

Factors driving market growth include decreasing sequencing costs, the use of whole exome sequencing technology for a variety of applications, and strategic alliances between key players and research institutes.

Moreover, market players are operating in the global exome sequencing market emphasis on product launches, approvals, and collaborations to gain market dominance and keep their product updated and in demand. For example, in November 2019, NantHealth, Inc. (US), a next-generation, personalized healthcare company, received FDA approval from Omics CoreSM, the first whole exome sequencer used to examine both tumor and somatic genes to determine the overall tumor mutation burden (TMB) in cancer tissue.

However, the lack of qualified professionals and ethical and legal concerns related to whole exome sequencing are hindering the growth of the industry.

Whole Exome Sequencing Market Segmentation

The global whole exome sequencing market has been segmented based on the product, technology, application, and end-user.

Based on the product, the global market for whole exome sequencing has been segmented into kits, sequencer, and services. Kits are further divided into DNA Fragmentation, A-Tailing, End Repair, Size Selection Kits, Target Enrichment, and Library Preparation. Services are further sub-segmented into Data Analysis (Bioinformatics), Sequencing Services, and Others.

Based on technology, the global market for whole exome sequencing has been classified as Sequencing by Synthesis (SBS), ION Semiconductor Sequencing, and others.

Based on application, the global market for whole exome sequencing has been segmented into diagnostics, drug discovery, development, agriculture, animal research, and others.

Based on end-user, the global market for whole exome sequencing has been segmented into research centers, government institutes, hospitals and diagnostics centers, pharmaceutical and biotechnology companies, and others.

Whole Exome Sequencing Market Regional Analysis

The global market for whole exome sequencing is segmented into the Americas, Europe, the Asia Pacific, and the Middle East & Africa.

The Americas were the biggest whole exome sequencing market in 2019. The expansion of the Americas market is due to the increasing prevalence of cancer and other chronic disorders and rising healthcare expenditure. In addition, favorable initiatives by the government and other organizations for the development and adoption of whole exome sequencing technologies are fueling the market growth for whole exome sequencing. For example, in 2018, the All Us Research Program, part of the National Institutes of Health, received more than USD 28.6 million in funding to establish three genome centers in the US.

Europe is the second-largest whole exome sequencing market in Western Europe, with the largest market share. The European market is projected to have a steady growth rate during the forecast period due to growing cancer cases and increasing genome sequencing programs. As per the International Agency for Cancer Research, there were nearly 4,229,662 cases of cancer in Europe in 2018. These huge cancer cases and increasing genome mapping programs are expected to have a significant impact on the growth of the whole exome sequencing market.

The Asia Pacific is projected to show the highest potential for market growth over the forecast period due to the rising patient pool and growing technological advancements. The rapid growth of the Asia Pacific region is due to an increase in per capita income and government initiatives to improve the quality of healthcare. China, India, and Australia have a profitable market for whole exome sequencing due to the growing elderly population.

In the Middle East & Africa, the whole exome sequencing market accounts for a substantial market share. Countries such as Kuwait, Saudi Arabia, and the UAE are expected to see steady growth due to a rise in cancer cases, increasing government efforts to enhance health care, and favorable reimbursement policies. Nevertheless, the rest of the Middle East and Africa may show inactive growth due to affordability and accessibility issues.

Whole Exome Sequencing Market Key Players

The prominent participants in the global whole exome sequencing market are Illumina Inc. (US), BGI (China), Eurofins Scientific (Belgium), Agilent Technologies, Inc. (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd (Switzerland), Ambry Genetics (US), GENEWIZ (US), Macrogen, Inc. (South Korea), Integragen SA (France), and others.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/whole-exome-sequencing-market-8763

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Handheld Surgical Devices Market Dynamics, Forecast, Analysis And Supply Demand 2020

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Handheld Surgical Devices Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Handheld Surgical Devices Market Analysis

The global handheld surgical devices market is expected to exhibit a strong CAGR of 6.8% over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The global handheld surgical devices market is likely to grow at a steady pace over the forecast period, leading to a high overall valuation by the end of the forecast period. The report studies the market’s major drivers and restraints, as well as the leading players operating in the global market. The impact of the COVID-19 pandemic on the handheld surgical devices market is also assessed in the report.

ALSO READ : https://www.medgadget.com/2020/07/handheld-surgical-devices-market-growth-2020-covid-19-impact-analysis-size-estimation-industry-share-top-company-analysis-regional-revenue-cagr-value.html

Handheld surgical devices are various types of devices used by surgeons during surgery. They are specially designed so as to enable surgeons to perform surgeries with a high accuracy. The degree of precision available in surgeries matters, as this results in fewer accidents or mishaps. This has led to a growing demand for handheld surgical devices made to a high standard. The medical devices industry has come up with new and improved standards for handheld surgical devices in recent years in order to ensure high standards in handheld surgical devices. This is likely to be a major driver for the global handheld surgical devices market over the forecast period.

The increasing demand for surgical procedures, especially cardiovascular, neurological, and ophthalmic surgeries, is likely to be a major driver for the global handheld surgical devices market. The increasing prevalence of sedentary lifestyles has resulted in a growing demand for cardiovascular surgeries to prevent serious consequences such as heart attacks. The increasing air pollution and increasing use of blue screens such as desktops and laptops, in addition to mobiles, has resulted in a growing demand for cataract and other ophthalmic surgeries. This is likely to remain a major driver for the global handheld surgical devices market over the forecast period. On the other hand, the lack of skilled and trained physicians and the stringent government regulations are likely to be the major restraints on the global handheld surgical devices market over the forecast period.

Handheld Surgical Devices Market Competitive Leaderboard:

Leading players in the global handheld surgical devices market include CooperSurgical Inc., KLS Martin, Aspen Surgical, Stryker, Thompson Surgical, Becton Dickinson and Company, Elite Medical, Medicon AG, Millennium Surgical Corp., Johnson & Johnson, Smith & Nephew, Medtronic, Pelion Surgical, Zimmer Biomet Holdings, Integra LifeSciences Corporation, and B. Braun Melsungen AG.

Handheld Surgical Devices Market Segmentation:

The global handheld surgical devices market is segmented on the basis of application, product, end use, and region.

By application, the global handheld surgical devices market is segmented into neurology, urology, orthopedics, gynecology, cardiovascular, wound closure, and others. Neurology and cardiology segments are likely to hold dominant shares in the global handheld surgical devices market over the forecast period.

By product type, the global handheld surgical devices market is segmented into forceps and spatulas, retractors, dilators, graspers, auxiliary devices, cutter devices, and others including punches, curettes, blunt dissectors, and snares. The auxiliary devices segment is segmented into clamps, cannulas, and closure devices. The cutter devices segment is segmented into trocars, lancets, and scissors.

By end use, the global handheld surgical devices market is segmented into hospitals, clinics, ambulatory surgical centers, research and academic institutes, and others. Clinics and hospitals held a dominant share in the global handheld surgical devices market in 2017 due to the high volume of surgical procedures carried out in hospitals and clinics.

Handheld Surgical Devices Market Regional Analysis:

The Americas dominated the global handheld surgical devices market in 2017 and is likely to remain the leading regional market for handheld surgical devices over the forecast period. The strong presence of numerous leading players in the Americas region is the major driver for the regional market. The growing prevalence of chronic diseases in the region is also likely to be a major driver for the global handheld surgical devices market over the forecast period. Europe holds the second largest share in the global handheld surgical devices market, followed by Asia Pacific.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/handheld-surgical-devices-market-7210

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Liquid Biopsy Market, Segments, Growth And Value Chain Analysis 2020

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Liquid Biopsy Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Liquid Biopsy Market Analysis

The global liquid biopsy market value is likely to touch USD 17,372.28 million at a whopping 28.0% CAGR between 2014- 2022, according to the new report by Market Research Future (MRFR). Liquid biopsy, simply put, is a minimally invasive test used to assess the cancer genetic status resting on the analysis of the circulating biomarker, which is present in the blood’s plasma component. Some of its wide applications include reproductive health, cancer, and others.

Various factors are adding to the global liquid biopsy market growth. According to the new MRFR report, such factors include growing awareness regarding the diagnosis of different types of cancer, multiple benefits of liquid biopsy such as less labor required, low cost, identification of specific mutations, and quick analysis, and extensive R&D in the diagnosis and treatment of cancer. Besides, the rising prevalence of cancer and burgeoning demand for non-invasive testing are also adding market growth.

ALSO READ : https://www.medgadget.com/2020/07/liquid-biopsy-market-size-to-touch-usd-17372-28-million-at-28-0-cagr-by-2022.html

On the contrary, tumor heterogeneity being the biggest challenge in cancer research may limit the global liquid biopsy market growth over the forecast period. Besides, the production process in its entirety being adversely impacted due to the temporary shutdown of industries and complete lockdown following the COVID-19 pandemic that has limited the overall blood collection tubes for the global liquid biopsy market is also hindering the market growth.

Liquid Biopsy Market Segmentation

The MRFR report gives an inclusive segmental analysis of the global liquid biopsy market report based on end user, samples, application, and types.

By types, the global liquid biopsy market is segmented into extracellular vesicles (EVS), circulating tumor DNA (CTDNA), circulating tumor cells (CTCS), and others. Of these, the circulating tumor cells segment will lead the market over the forecast period.

By application, the global liquid biopsy market is segmented into reproductive health, cancer, and others.

By sample, the global liquid biopsy market is segmented into forensic, urine sample, blood sample, and others. Of these, the blood sample segment will dominate the market over the forecast period.

By end user, the liquid biopsy market is segmented into academic & research centers, hospitals and laboratories, and others. Of these, the hospitals and laboratories segment will have a major share in the market over the forecast period.

Liquid Biopsy Market Regional Analysis

Based on the region, the global liquid biopsy market report covers the growth opportunities and recent trends across North America, Europe, the Asia Pacific (APAC), & the Middle East and Africa (MEA). Of these, North America will spearhead the market over the forecast period. Improving healthcare infrastructure, increasing prevalence of cancer, and surging demand for non-invasive treatment is adding to the global liquid biopsy market growth in the region. The US has the maximum share in the region.

The global liquid biopsy market in the APAC region is predicted to grow at a fast pace over the forecast period. The government’s focus on healthcare facilities, growing cancer cases, increased urbanization, and rising income are adding to the liquid biopsy market growth in the region.

The global liquid biopsy market in Europe is predicted to hold the second-largest share over the forecast period. Rising geriatric population, growing prevalence of cancer, and a huge base of research & academic institutes & biopharmaceutical companies are adding to the liquid biopsy market growth in the region.

The global liquid biopsy market in the MEA is predicted to have sound growth over the forecast period.

Liquid Biopsy Market Key Players

Eminent players profiled in the global liquid biopsy market report include Exosome Diagnostics (Massachusetts), SAGA Diagnostics AB (Sweden), Inivata Ltd (UK), Circulogene Theranostics (Alabama), Biocept, Inc. KGaA (US), Admera Health (US), Agena Bioscience Inc. (California), RainDance Technologies, Inc. (US), Trovagene, Inc. (California),and Guardant Health, Inc. (US).

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/liquid-biopsy-market-710

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Atherectomy Devices Research Report And Overview On Atherectomy Devices Market, 2020

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Atherectomy Devices Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Market Scenario

Atherectomy devices are built to either shave, cut, vaporize, laser or sand the plaques. The devices come with different indications. Different atherectomy devices have been invented for commercial use. The location of the plaque and type of blockage influence the choice of atherectomy device to be used. Some atherectomy devices are used only in the larger arteries on the upper portion of the knee, while other devices come with smaller catheters that are suitable for operating the arteries below the knee.

Atherectomy is a technique applied to eliminate atherosclerotic plaque from affected arteries. The plaques are in either peripheral or coronary arterial vasculature and may have distinct characteristics depending on the nature of the plaque. Atherectomy is used widely in cure of both peripheral and coronary arterial ailments. It is a minimally invasive endovascular surgery.

Also Read : https://www.medgadget.com/2020/07/covid-19-pandemic-impact-on-transthyretin-ttr-amyloidosis-market-2020-global-industry-size-share-business-opportunities-new-advancement-strategies-sales-revenue-regional-statistics.html

The worldwide Atherectomy devices industry is likely to develop remarkably over the forecast period. It is projected that the global atherectomy devices market will register a CAGR of 6.12% over the forecast period of 2018–2023. In 2017, the estimated market value was around 1.09 billion.

The growing rate of peripheral and coronary arterial diseases coupled with increasing demand for minimally invasive techniques is predicted to boost the growth of the atherectomy devices market. Minimally invasive surgical techniques deliver quicker recovery, quick procedural time, lesser risk of infections and complications. The worldwide atherectomy devices market is likely to witness noteable surge in demand due to exponential growth in the incidence of lifestyle-related ailments and elderly population.

Segmentation

The global atherectomy devices market is segmented on the basis of product type, application, and end user.

Based on application, the atherectomy devices market is segmented into cardiovascular, neurovascular, peripheral vascular, and others.

The atherectomy devices market, by product type is categorised into directional atherectomy systems, orbital atherectomy systems, photo-ablative (laser) atherectomy systems, rotational atherectomy systems, and others.

The directional atherectomy systems segment is expected to hold the largest share owing to the high treatment rate, whereas the photo-ablative (laser) atherectomy systems is expected to be the fastest growing segment owing to the growing preference by surgeons.

On the basis of end user, the market is segmented into hospitals, ambulatory surgery centers, and others.

On the basis of region, the global atherectomy devices market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and Latin America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, South Korea, and the rest of Asia-Pacific. The atherectomy devices market in the Middle East and Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Asia-Pacific was projected to be the fastest growing region for the global atherectomy devices market. This owes to the technological advancements resulting in the development of cost-effective atherectomy devices leading to high acceptance rate for the devices in the Asia-Pacific region. The Middle East and Africa holds the least share in the global atherectomy devices market due to the presence of economically diverse countries, and less initiatives taken by the government.

It is projected that the Americas dominated the global atherectomy devices market owing to the growth of the market in the North American region. This is largely attributed to the factors such as increase in research funding, and growing awareness about the high-end atherectomy devices among medical professionals. Europe is expected to hold the second largest share in the atherectomy devices market owing to growing healthcare infrastructure. Additionally, various initiatives by public and private organizations is anticipated to boost the growth of the atherectomy devices market.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/atherectomy-devices-market-7322

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Worldwide Transthyretin (TTR) Amyloidosis Market 2019 Outlook, Top 10 Industry Players Comprehensive Analysis And Forecast To 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Transthyretin (TTR) Amyloidosis Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide DemandTransthyretin (TTR) Amyloidosis Market Analysis

Market Research Future (MRFR) report on the global transthyretin (TTR) amyloidosis market (2018-2023) analyzes COVID-19 on the main factors that drive market growth. The study addresses competitors in the market and global market trends, offering a detailed summary of both growth factors and constraints, which may have a direct or indirect effect on the outlook of the industry during the forecast period.

Transthyretin (TTR) amyloidosis is a medical disorder characterized by the build-up of irregular protein deposits called amyloid (amyloidosis) in the body’s organs and tissues. It primarily affects the peripheral neuropathic or autonomic neuropathic system and the cardiac system. The cardiac type of transthyretin (TTR) amyloidosis puts patients at risk of arrhythmia, cardiomegaly, and orthostatic hypertension.

Transthyretin (TTR) Amyloidosis Market Key Players

Some of the key players identified by MRFR in this market are Alnylam Pharmaceuticals, Pfizer, Merck, Arcturus Therapeutics, Ionis Pharmaceuticals Inc., Corino Therapeutics Inc, Proclara Bioscience.

Transthyretin (TTR) Amyloidosis Market Dynamics

The global ATTR market is expected to show robust growth during the forecast period due to the probability of an increase in the number of ATTR drug launches, an increase in the Afro-American population as they are genetically susceptible to amyloidosis, an increase in people’s health awareness and the average income of individuals.

Nevertheless, the growth of this market can be hampered by strict regulatory policies, the high cost of ATTR drugs, the inaccurate diagnosis of ATTR disorders, and clinical trials’ limitations. Lack of information on this condition and inadequacy of advanced diagnostic methods in middle-income countries are significant market barriers.

Transthyretin (TTR) Amyloidosis Market Segmentation

The global transthyretin (TTR) amyloidosis market has been segmented based on disease type, treatment, gender, and end-user.

Based on the type of disease, the global market for transthyretin (TTR) amyloidosis has been segmented into transthyretin (TTR) familial amyloid cardiomyopathy, transthyretin (TTR) familial amyloid polyneuropathy, and others.

Based on treatment, the global market for transthyretin (TTR) amyloidosis has been segmented into small molecules treatment, organ transplantation, RNAi therapy and others. The segment for small molecules treatment is further divided into tafamidis and diflunisal.

Based on gender, the global market for transthyretin (TTR) amyloidosis has been segmented into males and females.

Based on the end-user, the global market for transthyretin (TTR) amyloidosis has been segmented into hospitals and clinics, ambulatory surgical centers, and others.

Transthyretin (TTR) Amyloidosis Market Regional Analysis

By region, the global market for transthyretin (TTR) amyloidosis has been segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas leads the market for transthyretin amyloidosis (TTR) due to a growing prevalence of amyloidosis among adults and the elderly and a rising geriatric population, which is a significant cause for this disease. For example, according to a study released by ASCO Journal in 2016, approximately 4,000 people develop amyloidosis per year in the United States. As a result, this growing patient pool will fuel demand growth during the forecast period. In addition, factors such as increasing government initiatives and support for research, the advancement of advanced medical treatment options, and the growing usage of technologically advanced medical diagnostic devices are likely to propel the market. The presence of pharmaceutical giants such as Pfizer, Merck, etc. is also driving market growth in this region.

Europe is the second-largest market and has a fair share of the overall market for transthyretin (TTR) amyloidosis. The European market is expected to show significant growth during the forecast period due to main factors such as the availability of advanced treatment facilities, increased spending on healthcare, as well as an increasing need for better healthcare infrastructure, and government initiatives to reform health care. Approximately 60 new cases of transthyretin (TTR) amyloidosis are recorded annually in the United Kingdom, and the age-specific incidence rate is between 5.1 and 12.8 per million per year. In addition, the growing demand for medical devices and the capability of people to afford diagnostics contribute to the industry’s growth. However, the inefficiency of treatment and the incorrect diagnosis is hindering the growth of the market in this area.

The Asia Pacific is anticipated to be the fastest-growing region. According to a study published by the United Nations in 2015, the number of older adults aged 60 years or older in the world is expected to rise by 56% between 2015 and 2030, of which 66% of the elderly reside in the Asia Pacific region. It makes the region vulnerable to transthyretin (TTR) amyloidosis as the chances of its occurrence increase with rising age. Due to a broad patient population, rapid adoption of healthcare technologies, government initiatives to enhance healthcare quality, and availability of favorable reimbursement and insurance policies, market growth will accelerate throughout the forecast period. In addition, major players such as Pfizer, Merck, etc. have developed their regional headquarters and manufacturing facilities in countries like Singapore, China, Japan, Korea, and Australia. As a result, the growth curve of the in transthyretin (TTR) amyloidosis market will show a positive growth pattern.

The Middle East and Africa are anticipated to exhibit the lowest growth in the market due to some key factors such as dearth of awareness and limited access and availability of treatment facilities. In the Middle East, Saudi Arabia and the United Arab Emirates are the major markets due to the development of the healthcare sector and the increasing availability of specialized care centers. However, the market may show steady growth due to the genetic vulnerability of Africans to transthyretin amyloidosis and government initiatives to augment the quality of healthcare in the region.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/transthyretin-amyloidosis-market-6155

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com